Skip to main content
. 2018 Oct 23;3(4):e10084. doi: 10.1002/jbm4.10084

Figure 2.

Figure 2

Femur aBMD and BMC measured by DXA. Male (A) and female (B) Col2.3‐hWNT16 TG mice treated with placebo had significantly higher femoral aBMD and BMC compared with WT placebo group at 28 days after pellet implantation. Female wild‐type mice treated with GC had significantly lower femoral aBMD and BMC compared with the placebo‐treated mice. Similarly, female Col2.3‐hWNT16 TG mice treated with GC had significantly lower femoral aBMD and BMC compared with the placebo‐treated mice. Values are given as mean ± SEM; *p < 0.05 and **p < 0.005 versus genotype‐matched placebo‐treated mice using Student's t test. GC = glucocorticoid.